Quick Answer
Syra Health Corp reported R&D Expense of $67.8 thousand for fiscal year 2025.
Syra Health Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $67.8K | -88.4% |
| 2024 | $585.1K | +143.8% |
| 2023 | $240.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $816.00 | -97.7% | -97.3% |
| June 30, 2025 | $29.7K | -89.3% | -20.1% |
| March 31, 2025 | $37.2K | -86.6% | +6.8% |
| September 30, 2024 | $34.8K | — | -87.5% |
| June 30, 2024 | $277.9K | — | +0.1% |
| March 31, 2024 | $277.5K | — | — |
- Syra Health Corp showed a decrease of -88.4% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Syra Health Corp’s r&d expense has declined by 71.7% (from $240.0 thousand to $67.8 thousand).
- The most recent figure is from Syra Health Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: